Drug therapy in nursing
(Book)
Author:
Contributors:
Published:
Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, [2012].
Format:
Book
Edition:
4th ed.
Physical Desc:
xvii, 1346 pages : color illustrations ; 29 cm
Status:
Description
Description not provided
Copies
Location
Call Number
Status
CMU Storage Books
RM125 .N83 2012
On Shelf
Citations
APA Citation (style guide)
Aschenbrenner, D. S., & Venable, S. J. (2012). Drug therapy in nursing. 4th ed. Philadelphia, Wolters Kluwer Health/Lippincott Williams & Wilkins.
Chicago / Turabian - Author Date Citation (style guide)Aschenbrenner, Diane S and Samantha J. Venable. 2012. Drug Therapy in Nursing. Philadelphia, Wolters Kluwer Health/Lippincott Williams & Wilkins.
Chicago / Turabian - Humanities Citation (style guide)Aschenbrenner, Diane S and Samantha J. Venable, Drug Therapy in Nursing. Philadelphia, Wolters Kluwer Health/Lippincott Williams & Wilkins, 2012.
MLA Citation (style guide)Aschenbrenner, Diane S. and Samantha J Venable. Drug Therapy in Nursing. 4th ed. Philadelphia, Wolters Kluwer Health/Lippincott Williams & Wilkins, 2012.
Note! Citation formats are based on standards as of July 2022. Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy.
More Copies In Prospector
Loading Prospector Copies...
Subjects
LC Subjects
OCLC Fast Subjects
More Details
Language:
English
ISBN:
9781608311514, 1608311511, 9781451187663, 1451187661
Notes
Bibliography
Includes bibliographical references and index.
Staff View
Grouped Work ID:
1bf55bb7-bffe-d927-9708-fe44b138a062
QR Code
Record Information
| Last Sierra Extract Time | Nov 23, 2024 07:47:42 AM |
|---|---|
| Last File Modification Time | Nov 23, 2024 07:48:02 AM |
| Last Grouped Work Modification Time | Nov 23, 2024 07:47:49 AM |
MARC Record
| LEADER | 07230cam a2200709 a 4500 | ||
|---|---|---|---|
| 001 | 710813028 | ||
| 003 | OCoLC | ||
| 005 | 20140127091024.0 | ||
| 008 | 110329t20122012paua b 001 0 eng | ||
| 010 | |a 2011013529 | ||
| 016 | 7 | |a 101557511 |2 DNLM | |
| 016 | 7 | |a 015960029 |2 Uk | |
| 016 | 7 | |a 016206403 |2 Uk | |
| 019 | |a 765141095 | ||
| 020 | |a 9781608311514 | ||
| 020 | |a 1608311511 | ||
| 020 | |a 9781451187663 | ||
| 020 | |a 1451187661 | ||
| 035 | |a (OCoLC)710813028 |z (OCoLC)765141095 | ||
| 040 | |a DNLM/DLC |b eng |c DLC |d YDX |d NLM |d YDXCP |d UKMGB |d CDX |d EEK |d BDX |d TTU |d OCLCF |d COM | ||
| 042 | |a pcc | ||
| 049 | |a COMA | ||
| 050 | 0 | 0 | |a RM125 |b .N83 2012 |
| 060 | 0 | 0 | |a 2011 L-555 |
| 060 | 1 | 0 | |a WB 330 |
| 082 | 0 | 0 | |a 615.5/8 |2 22 |
| 100 | 1 | |a Aschenbrenner, Diane S. |0 https://id.loc.gov/authorities/names/n2001130607 | |
| 245 | 1 | 0 | |a Drug therapy in nursing / |c Diane S. Aschenbrenner, Samantha J. Venable. |
| 250 | |a 4th ed. | ||
| 264 | 1 | |a Philadelphia : |b Wolters Kluwer Health/Lippincott Williams & Wilkins, |c [2012] | |
| 264 | 4 | |c ©2012 | |
| 300 | |a xvii, 1346 pages : |b color illustrations ; |c 29 cm | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a unmediated |b n |2 rdamedia | ||
| 338 | |a volume |b nc |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |g unit 1. |t Foundations for drug therapy in nursing. Nursing management of drug therapy / |r Diane S. Aschenbrenner -- |t Pharmaceuticals: development, safeguards, and delivery / |r Samantha J. Venable -- |t Drug administration / |r Diane S. Aschenbrenner -- |g unit 2. |t Core drug knowledge. Pharmacotherapeutics, pharmacokinetics, and pharmacodynamics / |r Diane S. Aschenbrenner -- |t Adverse effects and drug interactions / |r Diane S. Aschenbrenner -- |g unit 3. |t Core patient variables. Life span: children / |r Diane S. Aschenbrenner -- |t Life span: pregnant or breast-feeding women / |r Diane S. Aschenbrenner -- |t Life span: older adults / |r Diane S. Aschenbrenner -- |t Lifestyle: substance abuse / |r Samantha J. Venable -- |t Lifestyle, diet, and habits: nutrition and complementary medications / |r Samantha J. Venable -- |t Environmental: influences on drug therapy / |r Sanantha J. Venable -- |t Culture: considerations in drug therapy / |r Diane S. Aschenbrenner -- |g unit 4. |t Peripheral nervous system drugs. Drugs affecting adrenergic function / |r Diane S. Aschenbrenner and Samantha J. Venable -- |t Drugs affecting cholinergic function / |r Diane S. Aschenbrenner and Samantha J. Venable -- |g unit 5. |t Central nervous system drugs. Drugs relieving anxiety and promoting sleep / |r Barbara G. Huggins -- |t Drugs treating mood disorders / |r Barbara G. Huggins -- |t Drugs treating psychotic disorders and dementia / |r Faye Bembry and Diane S. Aschenbrenner -- |t Drugs treating seizure disorders / |r Diane S. Aschenbrenner -- |t Drugs producing anesthesia and neuromuscular blocking / |r Andrew R. Benson -- |t Drugs affecting muscle spasm and spasticity / |r Andrew R. Benson and Kelly A. Stauffacher -- |t Drugs treating Parkinson disease and other movement disorders / |r Samantha J. Venable and Peggy Jenkins -- |t Drugs stimulating the central nervous system / |r Samantha J. Venable and Jacqueline Gilreath -- |g unit 6. |t Analgesic and anti-inflammatory drugs. Drugs treating severe pain / |r Paul L. Sacamano and Diane S. Aschenbrenner -- |t Drugs treating mild to moderate pain, fever, inflammation, and migraine headache / |r Samantha J. Venable -- |t Drugs treating rheumatoid arthritis and gout / |r Samantha J. Venable -- |
| 505 | 0 | 0 | |g unit 7. |t Hematopoietic, cardiovascular and renal system drugs. Drugs affecting blood pressure / |r Diane S. Aschenbrenner -- |t Drugs affecting urinary output / |r Diane S. Aschenbrenner -- |t Drugs affecting lipid levels / |r Diane S. Aschenbrenner -- |t Drugs treating heart failure / |r Diane S. Aschenbrenner -- |t Drugs treating angina / |r Diane S. Aschenbrenner -- |t Drugs affecting cardiac rhythm / |r Nancy Sullivan -- |t Drugs affecting coagulation / |r Diane S. Aschenbrenner -- |t Drugs affecting hematopoiesis / |r Diane S. Aschenbrenner -- |g unit 8. |t Respiratory system drugs. Drugs affecting the upper respiratory system / |r Samantha J. Venable -- |t Drugs affecting the lower respiratory system / |r Samantha J. Venable -- |g unit 9. |t Gastrointestinal tract drugs. Drugs affecting the upper gastrointestinal tract / |r Samantha J. Venable and Janice J. Hoffman -- |t Drugs affecting the lower gastrointestinal tract / |r Samantha J. Venable and Janice J. Hoffman -- |g unit 10. |t Antimicrobial drugs. Principles of antimicrobial therapy / |r Samantha J. Venable -- |t Antibiotics affecting the bacterial cell wall / |r Samantha J. Venable -- |t Antibiotics affecting protein synthesis / |r Samantha J. Venable -- |t Drugs that are miscellaneous antibiotics / |r Samantha J. Venable -- |t Drugs treating urinary tract infections / |r Samantha J. Venable -- |t Drugs treating mycobacterial infections / |r Samantha J. Venable -- |t Drugs treating fungal infections / |r Samantha J. Venable -- |t Drugs treating viral infections / |r Samantha J. Venable -- |t Drugs treating HIV infection and AIDS / |r Samantha J. Venable and Gerry M. deJesus -- |t Drugs treating parasitic infections / |r Samantha J. Venable -- |g unit 11. |t Endocrine drugs. Drugs affecting corticosteroid levels / |r Samantha J. Venable and Gerry M. deJesus -- |t Drugs affecting blood glucose levels / |r Diane S. Aschenbrenner -- |t Drugs affecting pituitary, thyroid, parathyroid, and hypothalamic function / |r Joyce B. Vazaano -- |t Drugs affecting men's health and sexuality / |r Donna Rane-Szostak -- |t Drugs affecting women's health and sexuality / |r Anne B. Woods -- |t Drugs affecting uterine motility / |r Anne B. Woods -- |g unit 12. |t Immune system and cancer chemotherapy drugs. Drugs affecting the immune response / |r Brenda K. Shelton -- |t Targeted therapies / |r Brenda K. Shelton and Mikaela Olsen -- |t Drugs that are cell cycle-specific / |r Mikaela Olsen -- |t Drugs that are cell cycle-nonspecific / |r Mikaela Olsen. |
| 650 | 0 | |a Chemotherapy. |0 https://id.loc.gov/authorities/subjects/sh85023041 | |
| 650 | 0 | |a Pharmacology. |0 https://id.loc.gov/authorities/subjects/sh85100599 | |
| 650 | 0 | |a Nursing. |0 https://id.loc.gov/authorities/subjects/sh85093362 | |
| 650 | 1 | 2 | |a Drug Therapy. |0 https://id.nlm.nih.gov/mesh/D004358 |
| 650 | 2 | 2 | |a Pharmaceutical Preparations. |0 https://id.nlm.nih.gov/mesh/D004364 |
| 650 | 2 | 2 | |a Pharmacology. |0 https://id.nlm.nih.gov/mesh/D010600 |
| 650 | 7 | |a Chemotherapy. |2 fast |0 (OCoLC)fst00853595 | |
| 650 | 7 | |a Nursing. |2 fast |0 (OCoLC)fst01041731 | |
| 650 | 7 | |a Pharmacology. |2 fast |0 (OCoLC)fst01060259 | |
| 655 | 2 | |a Nurses Instruction. |0 https://id.nlm.nih.gov/mesh/D020488 | |
| 700 | 1 | |a Venable, Samantha J. |0 https://id.loc.gov/authorities/names/n2001130608 | |
| 907 | |a .b4146123x | ||
| 948 | |a MARCIVE Comp, in 2022.12 | ||
| 948 | |a MARCIVE Comp, 2018.12 | ||
| 948 | |a MARCIVE August, 2017 | ||
| 948 | |a MARCIVE extract Aug 5, 2017 | ||
| 989 | |1 .i82268782 |b 1080005971942 |d cusmb |g - |m |h 0 |x 0 |t 0 |i 0 |j 18 |k 140127 |o - |a RM125 |r .N83 2012 | ||
| 994 | |a C0 |b COM | ||
| 995 | |a Loaded with m2btab.ltiac in 2022.12 | ||
| 995 | |a Loaded with m2btab.ltiac in 2018.12 | ||
| 995 | |a Loaded with m2btab.ltiac in 2017.08 | ||
| 995 | |a Loaded with m2btab.ltiac in 2016 | ||
| 995 | |a Exported from Connexion by CMU | ||
| 998 | |e - |f eng |a cu | ||